BSC
AVXL icon

BOLTON SECURITIES CORPORATION’s Anavex Life Sciences AVXL Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$101K Hold
50,000
– – ﹤0.01% 1128
2026
Q2 		$130K Hold
50,000
– – ﹤0.01% 1036
2026
Q1 		$154K Buy
+50,000
New +$217K 0.01% 887

Other funds holding AVXL

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Summit Financial
Summit Financial Parsippany, New Jersey $9.42B AUM 19.31% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Private Advisor Group
Private Advisor Group Morristown, New Jersey $29.9B AUM 19.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's AVXL Position: Q3 2026 in Review

BOLTON SECURITIES CORPORATION held its Anavex Life Sciences (AVXL) position steady in Q3 2026 at 50,000 shares worth $101K. The position accounts for ﹤0.01% of the portfolio, ranked #1128.

BOLTON SECURITIES CORPORATION first reported a position in AVXL in Q1 2026 and has held it in 3 quarters since. The position peaked at $154K in Q1 2026. 99 funds tracked by Wall St. Rank hold AVXL as of Q3 2026.

  • BOLTON SECURITIES CORPORATION held 50,000 shares of Anavex Life Sciences worth $101K as of Q3 2026.
  • BOLTON SECURITIES CORPORATION left its Anavex Life Sciences share count unchanged in Q3 2026.
  • Anavex Life Sciences made up ﹤0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q3 2026, its #1128 holding.
  • BOLTON SECURITIES CORPORATION first reported a position in Anavex Life Sciences in Q1 2026 and has held it in 3 quarters since.
  • BOLTON SECURITIES CORPORATION's Anavex Life Sciences position peaked at $154K in Q1 2026.
  • 99 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q3 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q3 2026, filed 12 Nov 2026.